Related Experiment Video
Updated: Aug 31, 2026

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity
Published on: September 26, 2025
AI agents in clinical medicine: delegation, supervision, and the problem of correlated failure
Ethan Waisberg1, Joseph W Guarnieri2,3,4
1Department of Medical Genetics, University of Cambridge, Cambridge, UK. ew690@cam.ac.uk.
Abstract:
Clinical artificial intelligence has to date generated outputs upon which a clinician then acted. Agentic systems execute the task itself, completing a sequence of steps and returning finished work. Adoption has proceeded rapidly across other sectors while clinical uptake has remained confined largely to pilots, an interval that affords medicine an a opportunity to govern the technology deliberately rather than retrospectively. The governing question is thereby transformed from whether a prediction is accurate to whether a task may be entrusted, a question medicine has addressed throughout its history of training juniors under supervision. We argue that the appropriate frame for agentic systems is consequently delegation rather than prediction, and that the entrustment frameworks developed within postgraduate education furnish a serviceable structure of graded autonomy, task-level scope, and named supervisory responsibility. We then identify the point at which the correspondence ceases to hold. Supervision of human colleagues presupposes that errors are independent and idiosyncratic, such that mistakes arise individually and are detected individually. A single agent deployed across an institution generates one error process reproduced at scale. The consequence is that agentic systems cannot be adequately supervised through case-level review, and require instead the population-level surveillance characteristic of quality improvement.
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Obedience
Ethical Dilemmas II
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Therapeutic Drug Monitoring: Affecting Factors
Drug Control Governance: Regulatory Bodies and Their Impact